Biography
Carlotta Valensin is Research Study Coordinator for Prenatal Drivers of Infant Islet Autoimmunity (PISA) study, funded by Leona M. and Harry B. Helmsley Charitable Trust and embedded in a large pregnancy cohort study (INSIGHT and INSIGHT-2). Carlotta holds an MSc in Biomedical Engineering from Imperial College London and 2 years of work in the molecular diagnostics industry, where she gained extensive experience in project coordination and data management. Since March 2023, Carlotta's main responsibilities in the Department of Women and Children's Health involve day-to-day project coordination, as well as implementation, management and maintenance of administrative, recruitment, data collection, governance and analysis systems to ensure smooth running and success of the PISA Study.
Research
Gibbons Group
Every year, 15 million babies are born prematurely and 1 million die as a consequence. My lab focuses on understanding immune cell development and function in human neonates, including both those born at term and prematurely. We have identified novel T cell effector functions in neonates and factors that affect immune cell development post birth. We have ongoing research in both areas. These studies will promote our understanding of the developing immune system in human infants to identify those more at risk from inflammation and infection and subsequently reduce infant mortality - a current NHS target and huge health burden.
INSIGHT-2
Mechanistic Studies into Pregnancy Complications and their Impact on Maternal and Child Health
Tribe Lab
Through our mother-child cohorts, our goal is to improve outcomes for pregnant women and their children and promote health throughout the life course.
PISA: Prenatal drivers of infant ISlet Autoimmunity
As childhood onset of T1D becomes more prevalent, there is an increasing need to understand how early life exposures could influence the development of the child and predispose to the development of autoimmunity.
Research
Gibbons Group
Every year, 15 million babies are born prematurely and 1 million die as a consequence. My lab focuses on understanding immune cell development and function in human neonates, including both those born at term and prematurely. We have identified novel T cell effector functions in neonates and factors that affect immune cell development post birth. We have ongoing research in both areas. These studies will promote our understanding of the developing immune system in human infants to identify those more at risk from inflammation and infection and subsequently reduce infant mortality - a current NHS target and huge health burden.
INSIGHT-2
Mechanistic Studies into Pregnancy Complications and their Impact on Maternal and Child Health
Tribe Lab
Through our mother-child cohorts, our goal is to improve outcomes for pregnant women and their children and promote health throughout the life course.
PISA: Prenatal drivers of infant ISlet Autoimmunity
As childhood onset of T1D becomes more prevalent, there is an increasing need to understand how early life exposures could influence the development of the child and predispose to the development of autoimmunity.